¼¿ï´ëÇб³º´¿ø Á¦ 12 ȸ ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ Ãß°èÇмú´ëȸ : 2019-10-11±³À°ÀÏÀÚ : 2019-10-11
±³À°Àå¼Ò : ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ)
±³À°ÁÖÁ¦ :
Á¦ 12 ȸ ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ Ãß°èÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ
´ã´çÀÚ : ÁÖÁöÇö
¿¬¶ôó : 02-2072-0629
À̸ÞÀÏ :
joojihyun0512@gmail.com ±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀοø : 65¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 12:00~13:00 µî·Ï ()
±³À°½Ã°£ 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 13:00~13:20 Animal model of NMDAR encephalitis ÁÖ°Ç(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 13:20~13:40 Epidemiology of HSV and VZV encephalitis ¼±¿ìÁØ»ó(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 13:40~13:55 Immunotherapy in probable autoimmune encephalitis without detected autoantibody ÀÌ¿ìÁø(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 13:55~14:10 T cell receptor assessment in autoimmune neurologic disorder ½Å¿ë¿ø(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 14:10~14:25 Neuroinflammation in Status Epilepticus ±è¿µ¼ö(°æ»ó´ëº´¿ø)
±³À°½Ã°£ 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 14:25~14:40 Effect of Tocilizumab in an Experimental Epilepsy Model ÀÌÇÑ»ó(¼¿ï´ëº´¿ø)
ÈÞ½Ä 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 14:40~15:00 COFFEE BREAK ()
±³À°½Ã°£ 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 15:00~15:50 Metagenomics for Meningitis and Encephalitis Michael R. Wilson(UCSF)
Åä·Ð 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 15:50~16:00 Discussion ()
±³À°½Ã°£ 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 16:00~16:30 Opportunities and Challenges of Clinical Metagenomics: Lessons learnt from SNUH cases ¹®Àå¼·(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-11 ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç(1Ãþ) 16:30~16:35 MEETING ADJOURNMENT ±è¸¸È£(´ëÇѳú¿°/³ú¿°ÁõÇÐȸ ȸÀå)